购物车
- 全部删除
- 您的购物车当前为空
Anti-MI/R injury agent 1 (compound 18) 是一种口服有效的人参三醇衍生物,专用于抗心肌缺血/再灌注 (MI/R) 损伤。该化合物能增强经氧-葡萄糖剥夺和再灌注 (OGD/R) 诱导心肌细胞损伤模型中的细胞活力,显着缩小大鼠心肌梗死面积,减少循环心肌肌钙蛋白 I (cTnI) 的释放,并减轻心脏组织损害。
Anti-MI/R injury agent 1 (compound 18) 是一种口服有效的人参三醇衍生物,专用于抗心肌缺血/再灌注 (MI/R) 损伤。该化合物能增强经氧-葡萄糖剥夺和再灌注 (OGD/R) 诱导心肌细胞损伤模型中的细胞活力,显着缩小大鼠心肌梗死面积,减少循环心肌肌钙蛋白 I (cTnI) 的释放,并减轻心脏组织损害。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 8-10周 | |
50 mg | 询价 | 8-10周 |
产品描述 | Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, represents an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R) injury. It improves cell viability in cardiomyocytes subjected to oxygen-glucose deprivation and reperfusion (OGD/R)-induced injury. Furthermore, this compound significantly reduces myocardial infarction size, diminishes levels of circulating cardiac troponin I (cTnI), and mitigates cardiac tissue damage in rat models [1]. |
分子量 | 543.73 |
分子式 | C32H49NO6 |
CAS No. | 2387506-35-4 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容